- Safety and persistence of immunological response 6 months after intramuscular vaccination with an AS03-adjuvanted H1N1 2009 influenza vaccine: an open-label, randomized trial in Japanese children aged 6 months to 17 yearsAkihiko Saitoh
Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
Hum Vaccin Immunother 8:749-58. 2012..75 µg HA AS03-adjuvanted H1N1 2009 pandemic influenza vaccine in children aged 6 mo-17 y induced strong immune responses against the vaccine homologous strain that persisted for at least six months after the first vaccine dose...
- Current issues with the immunization program in Japan: can we fill the "vaccine gap"?Akihiko Saitoh
Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, 1 757 Asahimachi dori, Chuo Ku, Niigata 951 8510, Japan
Vaccine 30:4752-6. 2012....